Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Pinaki Biswas

3PUBLICATIONS

16CO-AUTHORS

Predictive and prognostic markersAllergyPharmacogenomics

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|May 20, 2026

Efficacy and Safety of Variable-Dose Versus Continuous-Dose Abrocitinib Treatment in Patients with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis.

|Sep 23, 2025

Do Allergic Comorbidities Alter the Efficacy and Safety of Abrocitinib or Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis?

Eric L Simpson, Jonathan I Silverberg, Bob Geng

|Feb 04, 2025

Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE.

Jonathan I Silverberg, Eric L Simpson, Andrew E Pink

Pageof 1

Frequent Collaborators

3 joint publications

Jonathan I Silverberg

3 joint publications

Eric L Simpson

1 joint publications

Andrew E Pink

1 joint publications

Stephan Weidinger

1 joint publications

Claire Clibborn

1 joint publications

Erman Güler

1 joint publications

Bob Geng

1 joint publications

José-Manuel Carrascosa

1 joint publications

Thomas Bieber

1 joint publications

Patrick M Brunner

Frequent Collaborators

3 joint publications

Jonathan I Silverberg

3 joint publications

Eric L Simpson

1 joint publications

Andrew E Pink

1 joint publications

Stephan Weidinger